[
    [
        {
            "time": "2018-10-15",
            "original_text": "Abbott, AbbVie settle TriCor marketing case for $25 million",
            "features": {
                "keywords": [
                    "Abbott",
                    "AbbVie",
                    "settle",
                    "TriCor",
                    "marketing",
                    "case",
                    "$25 million"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Abbott, AbbVie settle TriCor marketing case for $25 million",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-16",
            "original_text": "Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",
            "features": {
                "keywords": [
                    "Pharma",
                    "Stock",
                    "Roundup",
                    "MRK",
                    "BMY",
                    "Q3",
                    "Earnings",
                    "Cancer",
                    "Data",
                    "ESMO"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "iShares Core Dividend Growth ETF Experiences Big Inflow",
            "features": {
                "keywords": [
                    "iShares",
                    "Core",
                    "Dividend",
                    "Growth",
                    "ETF",
                    "Big",
                    "Inflow"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "iShares Core Dividend Growth ETF Experiences Big Inflow",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-10-18",
            "original_text": "The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, ACHC, ADNT, HTHT and CWH",
            "features": {
                "keywords": [
                    "Klein",
                    "Law",
                    "Firm",
                    "Reminds",
                    "Investors",
                    "Class",
                    "Actions",
                    "ABBV",
                    "ACHC",
                    "ADNT",
                    "HTHT",
                    "CWH"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "legal",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABBV, ACHC, ADNT, HTHT and CWH",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-19",
            "original_text": "AbbVie (ABBV) Q3 Earnings Preview: What's Shaping Up?",
            "features": {
                "keywords": [
                    "AbbVie",
                    "ABBV",
                    "Q3",
                    "Earnings",
                    "Preview"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Q3 Earnings Preview: What's Shaping Up?",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-10-20",
            "original_text": "SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline – November 20, 2018",
            "features": {
                "keywords": [
                    "SHAREHOLDER",
                    "ALERT",
                    "Bronstein",
                    "Gewirtz",
                    "Grossman",
                    "LLC",
                    "Notifies",
                    "Investors",
                    "Class",
                    "Action",
                    "AbbVie",
                    "Inc.",
                    "ABBV",
                    "Lead",
                    "Plaintiff",
                    "Deadline"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "legal",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline – November 20, 2018",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-10-21",
            "original_text": "A Performance Overview of JNJ’s Imbruvica, Velcade, and Zytiga",
            "features": {
                "keywords": [
                    "Performance",
                    "Overview",
                    "JNJ",
                    "Imbruvica",
                    "Velcade",
                    "Zytiga"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A Performance Overview of JNJ’s Imbruvica, Velcade, and Zytiga",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]